Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is T  [Clear All Filters]
Duan Z. Targeted DNase Hi-C. Methods Mol Biol. 2021;2157:65-83.
Menacho C, Prigione A. Tackling mitochondrial diversity in brain function: from animal models to human brain organoids. Int J Biochem Cell Biol. 2020:105760.
Trifilio S, Rubin H, Monacelli A, Mehta J. Tacrolimus dose modification in patients receiving concomitant isavuconazole after hematopoietic stem cell transplantation. J Oncol Pharm Pract. 2020:1078155220940416.
Salles G, Duell J, Barca EGonzález, Tournilhac O, Jurczak W, Liberati AMarina, Nagy Z, Obr A, Gaidano G, André M, et al. Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study. Lancet Oncol. 2020.
Zhang C, Xu Z, Yang S, Sun G, Jia L, Zheng Z, Gu Q, Tao W, Cheng T, Li C, et al. tagHi-C Reveals 3D Chromatin Architecture Dynamics during Mouse Hematopoiesis. Cell Rep. 2020;32(13):108206.
Samadian H, Farzamfar S, Vaez A, Ehterami A, Bit A, Alam M, Goodarzi A, Darya G, Salehi M. A tailored polylactic acid/polycaprolactone biodegradable and bioactive 3D porous scaffold containing gelatin nanofibers and Taurine for bone regeneration. Sci Rep. 2020;10(1):13366.
Fan C, Shah Z, Ullah H, Philonenko ES, Zhang B, Tan Y, Wang C, Zhang J, Samokhvalov IM. TALEN-mediated biallelic inactivation of MYB in human embryonic stem cell lines WAe001-A-45 and WAe001-A-46. Stem Cell Res. 2020;46:101854.
Yang N, Chen H, Gao Y, Zhang S, Lin Q, Ji X, Li N, Xu W, Liu Y, Jin S. Tanshinone IIA exerts therapeutic effects by acting on endogenous stem cells in rats with liver cirrhosis. Biomed Pharmacother. 2020;132:110815.
Chen Y, Wang M-H, Zhu J-Y, Xie C-F, Li X-T, Wu J-S, Geng S-S, Han H-Y, Zhong C-Y. TAp63α targeting of Lgr5 mediates colorectal cancer stem cell properties and sulforaphane inhibition. Oncogenesis. 2020;9(10):89.
Turkina A, Wang J, Mathews V, Saydam G, Jung CWon, Hashmi HHassan Al, Yassin M, Le Clanche S, Miljkovic D, Slader C, et al. TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries. Br J Haematol. 2020.
Reinecke JBrandon, Roberts RDavid. Targetable Intercellular Signaling Pathways Facilitate Lung Colonization in Osteosarcoma. Adv Exp Med Biol. 2020;1258:111-123.
Felber M, Steward CG, Kentouche K, Fasth A, Wynn RF, Zeilhofer U, Haunerdinger V, Volkmer B, Prader S, Gruhn B, et al. Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis. Blood Adv. 2020;4(9):1998-2010.
Birkhoff JC, Brouwer RWW, Kolovos P, Korporaal AL, Bermejo-Santos A, Boltsis I, Nowosad K, Hout MCGN, Grosveld FG, van IJcken WFJ, et al. Targeted Chromatin Conformation (T2C) analysis identifies novel distal neural enhancers of ZEB2 in pluripotent stem cell differentiation. Hum Mol Genet. 2020.
Yin P, Gui L, Wang C, Yan J, Liu M, Ji L, Wang Y, Ma B, Gao W-Q. Targeted Delivery of CXCL9 and OX40L by Mesenchymal Stem Cells Elicits Potent Antitumor Immunity. Mol Ther. 2020.
Pottoo FHyder, Javed N, Rahman J, Abu-Izneid T, Khan FAlam. Targeted delivery of miRNA based therapeuticals in the clinical management of Glioblastoma Multiforme. Semin Cancer Biol. 2020.
LE Coz M, Aktary Z, Watanabe N, Yajima I, Pouteaux M, Charoenchon N, Motohashi T, Kunisada T, Corvelo A, Larue L. Targeted knockout of β-catenin in adult melanocyte stem cells using a mouse line, Dct::CreER, results in disrupted stem cell renewal and pigmentation defects. J Invest Dermatol. 2020.
Sacco KA, Stack M, Notarangelo LD. Targeted Pharmacologic Immunomodulation for Inborn Errors of Immunity. Br J Clin Pharmacol. 2020.
Joseph MM, Ramya AN, Vijayan VM, Nair JB, Bastian BT, Pillai RK, Therakathinal ST, Maiti KK. Targeted Theranostic Nano Vehicle Endorsed with Self-Destruction and Immunostimulatory Features to Circumvent Drug Resistance and Wipe-Out Tumor Reinitiating Cancer Stem Cells. Small. 2020:e2003309.
Tan Y, Wu Q, Zhou F. Targeting acute myeloid leukemia stem cells: Current therapies in development and potential strategies with new dimensions. Crit Rev Oncol Hematol. 2020;152:102993.
Alibhai FJ, Li R-K. Targeting aged bone marrow for systemic rejuvenation. Aging (Albany NY). 2020.
Stagni V, Kaminari A, Sideratou Z, Nvestigation ESakellis, Vlahopoulos SA, Tsiourvas D. Targeting breast cancer stem-like cells using Chloroquine encapsulated by a Triphenylphosphonium-functionalized hyperbranched polymer. Int J Pharm. 2020:119465.
Abadir E, Silveira PA, Gasiorowski RE, Ramesh M, Romano A, Mekkawy AH, Lo T-H, Kabani K, Sutherland S, Pietersz GA, et al. Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia. Blood Adv. 2020;4(7):1206-1216.
Romanazzo S, Lin K, Srivastava P, Kilian K. Targeting cell plasticity for regeneration: from in vitro to in vivo reprogramming. Adv Drug Deliv Rev. 2020.
Su R, Dong L, Li Y, Gao M, Han L, Wunderlich M, Deng X, Li H, Huang Y, Gao L, et al. Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion. Cancer Cell. 2020.
Yamashita D, Bernstock JD, Elsayed G, Sadahiro H, Mohyeldin A, Chagoya G, Ilyas A, Mooney J, Estevez-Ordonez D, Yamaguchi S, et al. Targeting glioma-initiating cells via the tyrosine metabolic pathway. J Neurosurg. 2020:1-12.